Innospark Ventures

Innospark Ventures is a Boston-based venture capital firm focused on seed and early-stage investments, targeting startups across artificial intelligence, healthcare and life sciences, enterprise software, education, cybersecurity, and business services, with an emphasis on impact-driven AI ventures in Boston and the New England region. Founded in 2018, the firm typically funds rounds from $0.5 million to $5 million and prioritizes opportunities in healthcare, life sciences, and enterprise sectors to support early-stage innovation.

Howard Bornstein

Principal

Matt Fates

Partner

Jeff Knox

Associate

Mark Legare

Senior Associate

Venkat Srinivasan

Managing Director

Deepak Verma

Operating Partner

52 past transactions

Copernic Catalysts

Seed Round in 2024
Copernic Catalysts is a company focused on developing sustainable chemical catalysts and processes aimed at reducing the carbon footprint across various industries. The firm designs innovative zero- and low-carbon technologies that align with the current economic landscape of the chemical sector. Its advanced catalysts and processes support the production of sustainable chemicals and synthetic fuels, helping clients enhance energy efficiency, lower production costs, and access affordable zero-carbon chemicals. Through these efforts, Copernic Catalysts contributes to a more sustainable future in chemical manufacturing.

PhaseShift Technologies

Seed Round in 2024
PhaseShift Technologies develops an AI-driven platform to accelerate the design and development of advanced alloys for manufacturing. Its Rapid Alloy Design (RAD) technology, combined with multi-scale simulations, designs optimized alloys for specific applications, reducing the number of experiments and shortening development cycles. The platform also enables generation of synthetic data to address data scarcity in materials science. PhaseShift commercializes its portfolio through strategic partnerships with manufacturers, supporting improved performance, cost efficiency, and sustainability in material design and production.

Antiverse

Seed Round in 2024
Antiverse is an innovative biotechnology company specializing in accelerating drug development through its proprietary platform. This platform combines structural biology, machine learning, and medicine to facilitate quicker and more cost-effective breakthroughs in antibody discovery.

Haloo

Series A in 2024
Haloo empowers marketing and legal teams to collaborate effectively in trademark management. Its platform enables efficient and affordable searching, filing, and defense of trademarks, with built-in consultation from Google and former USPTO examiners ensuring up-to-date compliance.

Marigold Health

Series A in 2024
Marigold Health operates a social network community platform that provides AI-augmented chat support groups designed to assist individuals with behavioral health needs. By facilitating anonymous text-based group therapies, the company enables patients dealing with mental health and substance use conditions to connect and support one another. These support groups are complemented by the involvement of recovery coaches who help participants formulate personalized recovery plans. Marigold Health partners with treatment providers and managed care organizations within the Medicaid market, aiming to enhance patient engagement while allowing care teams to manage increased capacity effectively. Through its innovative approach, the company offers on-demand, stigma-free support for individuals seeking to improve their mental health.

BioIntelligence Technologies

Seed Round in 2024
BioIntelligence Technologies develops intelligent monitoring instruments for accelerating bioprocess development in the biotechnology industry. Their solutions enable real-time inline measurements of multiple bioprocess variables, helping to increase conversion yields and reduce product losses.

Via Scientific

Seed Round in 2024
Founded in 2022, Via Scientific develops an integrated bioinformatics operating system. This platform enables scientists and bioinformaticians to generate novel science efficiently by providing pipelines without coding, easy data incorporation, visualization tools, and amplifying experiment results with customizable metadata.

Karma Healthcare

Series A in 2023
Karman Healthcare are see a world where everyone has an opportunity and means to access equitable and affordable healthcare.

NODWIN Gaming

Series A in 2023
NODWIN Gaming is a leading esports and gaming company based in Gurugram, India. It operates an esports platform and produces events and related services, including content production, talent management, sponsorships and brand integration, enabling scalable fan experiences and monetization across the global gaming and media market. The company focuses on sports entertainment centered on esports, working with professional athletes, teams, creators and audiences, and operates across South Asia, Singapore, the Middle East and Turkey. It is a subsidiary of Nazara Technologies, reflecting its role within a larger ecosystem of gaming and live entertainment IPs.

ODAIA

Series B in 2023
ODAIA is a technology company offering an AI-powered customer data platform for the life sciences industry. Its platform blends data analysis, process mining, and artificial intelligence to deliver goal-driven commercial insights and automate processes as a software-as-a-service. It supports personalized selling by helping pharmaceutical teams map customer journeys and optimize engagement to ensure therapeutics reach patients who need them.

Persist AI

Seed Round in 2023
Persist AI is a company that aids pharmaceutical firms in the development of long-acting drug formulations by leveraging artificial intelligence and automation. Traditional formulation development is a lengthy process, typically spanning 5 to 10 years, which includes extensive pre-clinical and clinical testing phases. Persist AI aims to significantly reduce this timeline by streamlining pre-clinical formulation development to just three months, enhancing the efficiency of the drug development process by 50%. The company employs AI-driven automation technologies, such as automated drug release testing and high-throughput formulation screening, to facilitate quicker and more reliable drug formulation. By doing so, Persist AI not only accelerates drug development but also contributes to improving patient outcomes.

Antiverse

Seed Round in 2023
Antiverse is an innovative biotechnology company specializing in accelerating drug development through its proprietary platform. This platform combines structural biology, machine learning, and medicine to facilitate quicker and more cost-effective breakthroughs in antibody discovery.

Dyania Health

Seed Round in 2022
Dyania Health develops and deploys an AI-powered platform called Synapsis AI that automates manual chart review, a time-consuming task in modern healthcare, enabling clinicians to deliver optimal care when patients need it. The platform is used by large healthcare systems to enable enterprise-wide clinical trial pre-screening, automate chart review for observational studies, and automate complex registry reporting, reducing manual workloads and improving accuracy and timeliness. By analyzing unstructured electronic medical record data with artificial intelligence and machine learning, Dyania Health helps identify potential candidates for clinical drug trials, enhancing productivity and efficiency of clinical research teams.

Kreedo Early Childhood Solutions

Seed Round in 2022
Kreedo is an Edtech company that offers customers an end-to-end solution, from naming their preschool, marketing support, layout, admissions process, and so on, to running a premium preschool, which includes curriculum, educational materials, teacher and owner training, and assessment solutions.

AirWorks

Venture Round in 2022
AirWorks specializes in automated mapping solutions for the construction industry. Founded in 2018, it leverages AI-powered technology to create maps from aerial data, streamlining the pre-construction process and serving major civil engineering companies.

Rubick.ai

Funding Round in 2022
Rubick, established in 2015 is one of the fastest-growing eCommerce enablement platforms leveraging AI to automate the catalog creation. We specialize in cataloging and digital readiness for marketplaces, brands, and sellers. Rubick is a one-stop solution platform for brick-and-mortar Marketplaces & Online businesses. We offer an end-to-end full-stack Product Information, Cataloging, and Marketing platform as a solution for your eCommerce business. Rubick has cataloged over 7Mn SKUs for brands like Decathlon, Just In Time, Amazon, Hudson Bay US, Adidas, TLC UAE, and many more.

Text Mercato

Seed Round in 2022
Text Mercato is a technology-based content writing solution provider that uses a custom-built platform and algorithms to deliver high-quality work. It offers content writing and distribution services for ecommerce platforms to onboard sellers and catalog products, and provides analytical reporting on content quality, including rating, English quality, word density, and blacklisted words, with recommendations for word usage. The company also offers copywriting services on the developed content. Pricing is based on content type, desired quality, order size, and timelines. Founded in 2015 and headquartered in Bangalore, India.

Wyebot

Venture Round in 2022
Wyebot, Inc. is a technology company based in Marlborough, Massachusetts, specializing in wireless intelligence and automation. Founded in 2016, it offers an AI-driven platform that analyzes and optimizes wireless networks, addressing issues such as intermittent WiFi performance and ensuring business continuity through real-time alerts. The platform utilizes artificial intelligence, machine learning, and fog-computing technologies to automatically identify problems and provide actionable solutions, significantly reducing the time required for problem resolution. Wyebot primarily serves corporate enterprises, educational institutions, managed service providers, healthcare organizations, and entertainment venues, enhancing their ability to manage and optimize their wireless ecosystems effectively.

Zeta Surgical

Seed Round in 2022
Zeta Surgical is a digital surgery company dedicated to enhancing the accuracy, safety, and accessibility of image-guided procedures. It has developed an advanced navigation and robotics platform that utilizes computer vision and artificial intelligence to provide real-time image guidance at the point-of-care. This technology enables the overlay of 3D anatomical images, such as ultrasound and CT scans, directly within patients, while simultaneously tracking the positions of surgical instruments. By improving the visualization of surgical environments, Zeta Surgical's tools facilitate more effective and safer operations across various medical fields, including emergency care and interventional medicine. Founded by Harvard graduates and faculty, the company collaborates with leading hospitals and universities to advance its innovative solutions.

ArrePath

Seed Round in 2022
ArrePath is a biotechnology company focused on developing innovative therapies to combat drug-resistant infections. Its proprietary platform enables the creation of new medicines targeting multiple pathways, potentially enhancing efficacy and reducing development risks.

Starling Medical

Seed Round in 2022
Starling Medical is focused on creating a remote patient monitoring platform that facilitates at-home urine diagnostics, aiming to integrate seamlessly into everyday bathroom routines. The company designs healthcare devices that utilize mass spectroscopy-based sensors for continuous monitoring and early detection of health issues through urine analysis. By tracking changes in urine composition over time, Starling Medical's technology enables timely intervention for patients and healthcare providers, potentially preventing complications and reducing the need for hospitalizations. The organization is dedicated to developing predictive technology that enhances early detection of chronic health concerns, ultimately improving patient outcomes.

Entri

Series A in 2022
Entri is a vernacular language learning platform aimed at teachers and students, focusing on preparing job aspirants for government and private sector examinations in India. The platform has reportedly been utilized by up to 750,000 students and 2,300 teachers, offering a variety of learning resources including mock tests, adaptive assessments, flashcards, and video lessons. Entri's content is designed to be accessible in local languages, thus enabling users to engage with competitive exam preparation in a language they are comfortable with. This approach not only enhances the learning experience but also supports individuals in achieving their career goals.

ODAIA

Series A in 2022
ODAIA is a technology company offering an AI-powered customer data platform for the life sciences industry. Its platform blends data analysis, process mining, and artificial intelligence to deliver goal-driven commercial insights and automate processes as a software-as-a-service. It supports personalized selling by helping pharmaceutical teams map customer journeys and optimize engagement to ensure therapeutics reach patients who need them.

Zorus

Series A in 2021
Founded in 2017, Zorus specializes in cloud-based cybersecurity solutions for small and medium-sized businesses. Its platform detects and prevents malware threats directly from the cloud, ensuring robust protection and regulatory compliance.

Novig

Seed Round in 2021
Novig operates a commission-free, high-frequency sports betting exchange that lets users bet and trade across multiple sports and events. The platform supports pre-game and in-game trading, live odds, and social betting, enabling players to place bets directly against friends or the market and to monitor performance. By removing traditional sportsbook commissions, Novig offers an alternative betting model centered on direct peer-to-peer interaction and real-time liquidity.

AdeptMind

Series A in 2021
AdeptMind is a Toronto-based SaaS company that develops an AI-powered e-commerce product discovery and search platform. Founded in 2016, it uses deep learning and natural language processing to deliver personalized search results and smart filtering, helping online retailers reduce no-result searches. The platform collects data across all products to power recommendations without requiring third-party search tools, and it targets shopping center marketplaces and e-commerce product discovery.

Deeplite

Seed Round in 2021
Deeplite is a Montreal-based company that specializes in AI-driven optimization software for deep neural networks (DNNs) designed for deployment on both cloud servers and edge devices. The company's flagship product, Neutrino, utilizes a unique multi-objective design space exploration approach to automatically optimize DNN models, making them smaller, faster, and more energy-efficient. This technology addresses the challenges associated with deploying deep learning models on limited hardware, ensuring that they can operate effectively in real-time applications without compromising performance or battery life. Deeplite's solutions cater to various sectors, including automotive, smartphones, smart cameras, and IoT devices, ultimately enabling the integration of advanced AI capabilities into everyday technology.

Perygee

Seed Round in 2020
Perygee offers an integrated automation suite designed to streamline enterprise workflows. Its platform combines asset information management, security stakeholder collaboration, and no-code data modeling tools, aiming to enhance operational efficiency and cybersecurity.

The Routing Company

Seed Round in 2020
Founded by MIT researchers and industry veterans in 2018, The Routing Company develops a real-time driver and rider application for shared rides. It offers fleet management solutions, including private fleets, demand-responsive transit, analytics dashboards, and transit/paratransit services. Leveraging proprietary AI, the company's platform optimizes vehicle routing from multiple points of demand to one vehicle, enhancing transport equity, accessibility, cost efficiency, and sustainability.

Encora Therapeutics

Pre Seed Round in 2020
Founded in 2018, Encora Therapeutics specializes in developing wearable neurostimulation devices designed for individuals with neurological movement disorders. Their technology aims to provide personalized, non-invasive remedies to help patients regain independence and control.

AirWorks

Seed Round in 2020
AirWorks specializes in automated mapping solutions for the construction industry. Founded in 2018, it leverages AI-powered technology to create maps from aerial data, streamlining the pre-construction process and serving major civil engineering companies.

VODA.ai

Seed Round in 2020
VODA.ai is an artificial intelligence company based in Boston, Massachusetts, founded in 2017. It specializes in developing cloud-based software that assists water utilities in virtually assessing the condition and risk of their underground pipe systems. The software employs AI to evaluate the remaining lifespan of pipes and ranks them by Business Risk Exposure, incorporating factors such as the Likelihood of Failure and Consequence of Failure. This enables utilities to prioritize maintenance and replacement projects effectively, optimizing capital investments and enhancing operational efficiency. VODA.ai's technology not only helps reduce water loss but also contributes to sustainability goals by decreasing CO2 emissions and maximizing energy efficiency. Its clientele includes major metropolitan areas such as Las Vegas and Boston.

VideaHealth

Seed Round in 2020
VideaHealth develops AI software that automatically detects dental pathologies in imaging, providing real‑time second opinions and visual case presentations to improve diagnosis accuracy, treatment planning, and case acceptance. Founded in 2018 and headquartered in Cambridge, Massachusetts, the company’s VideaDetect platform helps dentists reduce missed disease rates, enhance patient communication, and streamline practice operations and insurance claims through analytics.

Intelligent Machines Lab

Seed Round in 2020
Intelligent Machines Lab is a practical, traceable, contextual AI solution designed for sparse-data situations to empower their clients. Their products enable real-time research, automate complex assessments, and facilitate quality writing. They offer custom solutions involving the understanding of unstructured content to help their clients solve problems.

Neurable

Series A in 2019
Neurable develops AI-powered neurotechnology for brain-computer interfaces. Its platform translates brain signals into actionable inputs, enabling users to interact with software and devices using only their thoughts.

Wyebot

Seed Round in 2019
Wyebot, Inc. is a technology company based in Marlborough, Massachusetts, specializing in wireless intelligence and automation. Founded in 2016, it offers an AI-driven platform that analyzes and optimizes wireless networks, addressing issues such as intermittent WiFi performance and ensuring business continuity through real-time alerts. The platform utilizes artificial intelligence, machine learning, and fog-computing technologies to automatically identify problems and provide actionable solutions, significantly reducing the time required for problem resolution. Wyebot primarily serves corporate enterprises, educational institutions, managed service providers, healthcare organizations, and entertainment venues, enhancing their ability to manage and optimize their wireless ecosystems effectively.

The Routing Company

Seed Round in 2019
Founded by MIT researchers and industry veterans in 2018, The Routing Company develops a real-time driver and rider application for shared rides. It offers fleet management solutions, including private fleets, demand-responsive transit, analytics dashboards, and transit/paratransit services. Leveraging proprietary AI, the company's platform optimizes vehicle routing from multiple points of demand to one vehicle, enhancing transport equity, accessibility, cost efficiency, and sustainability.

Entromy

Pre Seed Round in 2019
Entromy develops a real-time platform that surfaces business risks, issues, and ideas by automating the collection of employee feedback at scale. The platform uses natural language processing to synthesize insights from surveys and other inputs, delivering executive-level reporting with quantified metrics and prioritized actions. It supports organizational due diligence, post-merger integration, transformations, rapid growth of distributed teams, and ongoing performance improvement by providing real-time visibility into organizational health.

Know Your Meds

Pre Seed Round in 2019
KnowYourMeds is a new, AI based mobile application available on iOS and Android devices. The app provides users with proactive, profile-based information on all the medications you (and your loved ones) are taking. Information consists of dosage instructions, regulatory warnings, drug interactions, reported side and adverse effects as well as interactions with food and drinks. The app provides smart pill reminder features to ensure that you and your dependents never miss a dose, as well as prescription refills. Advanced users will also have access to the latest world-wide articles and peer reviewed medical papers on medications and disease conditions.

Ava Robotics

Series A in 2019
Ava Robotics Inc. is a robotics technology company based in Cambridge, Massachusetts, specializing in the design and development of autonomous robots for workplace environments. The company focuses on integrating autonomous mobility with high-definition video conferencing, allowing remote employees to participate actively in workplace activities. Ava Robotics' intelligent robots enable remote workers to attend meetings and navigate office spaces, enhancing collaboration and ensuring safety. By prioritizing user experience and operational efficiency, Ava Robotics aims to empower individuals and improve business processes through innovative robotic solutions.

Nutrimedy

Seed Round in 2019
Nutrimedy, Inc. is a Brookline, Massachusetts-based company that specializes in providing an innovative online platform for nutritional counseling. Established in 2016, Nutrimedy connects users with dietitians nationwide, allowing individuals to find professionals based on their preferred language and specific dietary needs. The company offers several services, including Nutrimedy Core, which links users to dietitians, and nuExpecting, a platform tailored for pregnant individuals. By integrating evidence-based clinical nutrition with advanced technology and behavioral health approaches, Nutrimedy aims to enhance access to personalized and affordable nutritional support, addressing a wide range of health conditions such as diabetes, acid reflux, and celiac disease. Through its B2B partnerships with healthcare providers, biotech, medtech, and insurance organizations, Nutrimedy strives to improve patient access to expert nutrition care and provide real-time solutions for healthier eating habits.

Ava Robotics

Seed Round in 2019
Ava Robotics Inc. is a robotics technology company based in Cambridge, Massachusetts, specializing in the design and development of autonomous robots for workplace environments. The company focuses on integrating autonomous mobility with high-definition video conferencing, allowing remote employees to participate actively in workplace activities. Ava Robotics' intelligent robots enable remote workers to attend meetings and navigate office spaces, enhancing collaboration and ensuring safety. By prioritizing user experience and operational efficiency, Ava Robotics aims to empower individuals and improve business processes through innovative robotic solutions.

PathAI

Series B in 2019
PathAI, Inc. is a technology company that specializes in developing artificial intelligence solutions for pathology laboratories. Founded in 2016 and headquartered in Boston, Massachusetts, with an additional office in Austin, Texas, PathAI focuses on enhancing the accuracy and efficiency of cancer diagnosis and treatment. The company's platform employs machine and deep learning techniques to analyze large datasets, assisting pathologists in making rapid and precise diagnoses for patients. By addressing complex challenges in pathology, PathAI aims to facilitate personalized medicine and improve patient outcomes by identifying individuals who may benefit from innovative therapies.

Rize

Series B in 2019
Rize Inc. is a Woburn, Massachusetts-based company founded in 2012 that specializes in 3D printing technology. The company manufactures full-color, multi-material industrial 3D printers designed for office-friendly environments. Rize's innovative hybrid 3D printers combine material extrusion and material jetting, allowing for a seamless one-touch experience in producing parts that closely resemble those made through injection molding. This technology supports sustainable and inclusive innovation, enabling businesses to adopt additive manufacturing at scale. Rize also provides additive labs and solutions tailored for small to medium-sized enterprises, as well as applications in tooling, fixtures, and jigs. The company focuses on connecting its products to Industry 4.0 technologies, aiming to deliver the lowest total cost of ownership for its customers.

Entri

Seed Round in 2019
Entri is a vernacular language learning platform aimed at teachers and students, focusing on preparing job aspirants for government and private sector examinations in India. The platform has reportedly been utilized by up to 750,000 students and 2,300 teachers, offering a variety of learning resources including mock tests, adaptive assessments, flashcards, and video lessons. Entri's content is designed to be accessible in local languages, thus enabling users to engage with competitive exam preparation in a language they are comfortable with. This approach not only enhances the learning experience but also supports individuals in achieving their career goals.

AirWorks

Seed Round in 2019
AirWorks specializes in automated mapping solutions for the construction industry. Founded in 2018, it leverages AI-powered technology to create maps from aerial data, streamlining the pre-construction process and serving major civil engineering companies.

Olaris

Venture Round in 2019
Founded in 2013, Olaris is dedicated to transforming disease diagnosis and treatment. Utilizing its CEREBRO platform, which integrates metabolomics and machine learning, the company discovers and develops precision diagnostics under its myOLARIS™ brand.

Javelin Biotech

Pre Seed Round in 2019
Javelin Biotech is a company focused on enhancing predictive drug discovery to improve the performance of drugs in humans. It operates a platform that provides biopharmaceutical companies with human-relevant in-vitro data alongside computational biology and data analytics. This approach enables pre-clinical drug discovery teams to optimize absorption, distribution, metabolism, excretion, toxicity (ADME(T)), and pharmacodynamics (PD) properties. By identifying human-relevant targets, Javelin Biotech accelerates the drug discovery and development process, facilitating more effective and timely approval of new therapeutics.

English Helper

Venture Round in 2019
EnglishHelper, Inc. specializes in technology solutions aimed at enhancing English language proficiency. Founded in 2008 and based in Dedham, Massachusetts, the company offers products such as ReadToMe, which focuses on improving reading, comprehension, and spoken English skills, and WritingAssistant, an application that enhances writing effectiveness. These solutions cater to a diverse audience, including schools, higher education institutions, vocational training centers, businesses, and individual learners. EnglishHelper Technologies Pvt. Ltd., a subsidiary established in 2009, further complements this mission by providing accessible technology enabled learning that simplifies the process of acquiring English language skills. Through its innovative platforms, EnglishHelper seeks to support users in becoming proficient in reading, writing, listening, and speaking English, thereby addressing the growing need for English literacy in both social and professional contexts.

Rize

Series B in 2018
Rize Inc. is a Woburn, Massachusetts-based company founded in 2012 that specializes in 3D printing technology. The company manufactures full-color, multi-material industrial 3D printers designed for office-friendly environments. Rize's innovative hybrid 3D printers combine material extrusion and material jetting, allowing for a seamless one-touch experience in producing parts that closely resemble those made through injection molding. This technology supports sustainable and inclusive innovation, enabling businesses to adopt additive manufacturing at scale. Rize also provides additive labs and solutions tailored for small to medium-sized enterprises, as well as applications in tooling, fixtures, and jigs. The company focuses on connecting its products to Industry 4.0 technologies, aiming to deliver the lowest total cost of ownership for its customers.

English Helper

Seed Round in 2017
EnglishHelper, Inc. specializes in technology solutions aimed at enhancing English language proficiency. Founded in 2008 and based in Dedham, Massachusetts, the company offers products such as ReadToMe, which focuses on improving reading, comprehension, and spoken English skills, and WritingAssistant, an application that enhances writing effectiveness. These solutions cater to a diverse audience, including schools, higher education institutions, vocational training centers, businesses, and individual learners. EnglishHelper Technologies Pvt. Ltd., a subsidiary established in 2009, further complements this mission by providing accessible technology enabled learning that simplifies the process of acquiring English language skills. Through its innovative platforms, EnglishHelper seeks to support users in becoming proficient in reading, writing, listening, and speaking English, thereby addressing the growing need for English literacy in both social and professional contexts.

Persist AI

Persist AI is a company that aids pharmaceutical firms in the development of long-acting drug formulations by leveraging artificial intelligence and automation. Traditional formulation development is a lengthy process, typically spanning 5 to 10 years, which includes extensive pre-clinical and clinical testing phases. Persist AI aims to significantly reduce this timeline by streamlining pre-clinical formulation development to just three months, enhancing the efficiency of the drug development process by 50%. The company employs AI-driven automation technologies, such as automated drug release testing and high-throughput formulation screening, to facilitate quicker and more reliable drug formulation. By doing so, Persist AI not only accelerates drug development but also contributes to improving patient outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.